Welcome to Almac Discovery
Almac Discovery is focused on the discovery and development of novel and innovative approaches to the treatment of cancer and associated conditions, with the goal of developing biomarkers or diagnostic tools in parallel with each potential new therapeutic.
We have significant experience in the discovery and development of both small molecules and peptide therapeutics and have taken programmes through all stages from target finding to Phase I clinical trials as evidenced in our pipeline. Whilst we are committed to developing our portfolio of assets through to clinical proof of concept, we would welcome interest from parties seeking to engage in discussion around partnering or licensing our assets at an earlier stage of the development process.
We are taking a dual approach to the identification of new validated oncology targets by building new platforms to identify novel targets in oncology and collaborating with academia to identify new targets in cancer with associated drug leads.
Almac Discovery is part funded by the European Regional Development Fund (ERDF) under the European Sustainable Competitiveness Programme for Northern Ireland.